COMBINATION THERAPIES FOR TREATMENT OF HCV

The present disclosure is directed to the use of a combination of simeprevir, daclatasvir, and sofosbuvir for the treatment of hepatitis C virus infection.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	VANDEVOORDE ANN TAMARA, NOVIELLO STEPHANIE, BEUMONT MARIA GLORIA, BEETS GRETA IRENE A, JACQUEMYN BERT, LUO DONGHAN, MAHADEVAN SIVI, HUGHES ERIC A, VAN REMOORTERE PETER JOSEF MARIA, VIJGEN LEEN ROGER ITTA, KAKUDA THOMAS NAOKI, PICCHIO GASTON RAFAEL
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present disclosure is directed to the use of a combination of simeprevir, daclatasvir, and sofosbuvir for the treatment of hepatitis C virus infection.